Endokrinologie-Leitlinien
ClariMed durchsucht endokrinologische Leitlinien von AWMF, DGE und internationalen Fachgesellschaften. Schilddrüsenerkrankungen, Diabetes, Nebenniere -- quellenbasiert.
Jetzt kostenlos suchenEvidenzbasiert · Kostenlos · Ohne Anmeldung · DSGVO-konform
Das suchen Ärzte wirklich
Anonymisierte Suchanfragen der letzten Woche
“TSH-Ziel bei papillärem Schilddrüsenkarzinom mit exzellenter Prognose?”
“Hypothyreose -- Therapie”
“Hyperthyreose -- Diagnostik und Therapie”
“21-Hydroxylase-Mangel -- Behandlung des Adrenogenitalen Syndroms”
“Hypoparathyreoidismus -- Behandlungsoptionen”
Jede Anfrage erhält eine evidenzbasierte Antwort mit direktem Link zur Originalleitlinie.
Probieren Sie es aus
Thyreotoxische Krise -- Diagnostik und Akuttherapie
Endokrinologie-Leitlinien auf ClariMed
146 Leitlinien mit redaktioneller Zusammenfassung
ADAADA Standards of Care in Diabetes 2026: Chapter 1 - Improving Care and Promoting Health in Populations2026ADAADA Standards of Care in Diabetes 2026: Chapter 12 - Retinopathy, Neuropathy, and Foot Care2026ADAADA Standards of Care in Diabetes 2026: Chapter 13 - Older Adults2026ADAADA Standards of Care in Diabetes 2026: Chapter 14 - Children and Adolescents2026ADAADA Standards of Care in Diabetes 2026: Chapter 16 - Diabetes Care in the Hospital2026ADAADA Standards of Care in Diabetes 2026: Chapter 4 - Comprehensive Medical Evaluation and Assessment of Comorbidities2026ADAADA Standards of Care in Diabetes 2026: Chapter 5 - Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes2026ADAADA Standards of Care in Diabetes 2026: Chapter 7 - Diabetes Technology2026NICEThyroid disease: assessment and management2026NICEType 1 diabetes in adults2026Brazilian Society of CardiologyPosition Statement on Cardiometabolic Health Across the Womans Life Course 20252025Diabetes CanadaDiabetes Canada Chapter 42: Diabetes and Metabolic Dysfunction-associated Steatotic Liver Disease in Adults (2025)2025Gemeinsamer Bundesausschuss (G-BA)DMP-Anforderungen-Richtlinie (G-BA) - Konsolidierte Fassung2025NICEAdrenal insufficiency: identification and management2025NICEDiabetes in children and young people2025NICEOverweight and obesity management2025NICEThyroid cancer: assessment and management2025SIGNSIGN 172: Prevention and remission of type 2 diabetes2025USPSTFScreening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.2025ADAADA 2024 Standards of Care in Diabetes2024ADAADA Standards of Care in Diabetes 2024 - Complete Standards2024ADAADA Standards of Medical Care in Diabetes 2024 - NursingCenter Summary2024AWMFNationale VersorgungsLeitlinie Typ-2-Diabetes (NVL, 2024)2024CDCCDC Guidelines for Diabetes Management2024Diabetes CanadaDiabetes Canada 2024 Clinical Practice Guidelines Quick Reference Guide2024EASDConsensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes (ADA/EASD 2024)2024GuidelineEASDHyperglycaemic Crises in Adults With Diabetes: A Consensus Report by ADA and EASD (2024)2024GuidelineEASDThe use of automated insulin delivery around physical activity and exercise in type 1 diabetes: EASD Position Statement (2024)2024GuidelineEASLEASL Clinical Practice Guidelines on NAFLD/MASLD (2024)2024GRADEEASLEASL-EASD-EASO 2024 Clinical Practice Guidelines on MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)2024EASLEASL-EASD-EASO Clinical Practice Guidelines on MASLD (Supplementary Material)2024NICECG146: Osteoporosis: assessing the risk of fragility fracture2024ANICENG145: Thyroid disease: assessment and management2024ANICENG17: Type 1 diabetes in adults: diagnosis and management2024ANICENG23: Menopause: diagnosis and management2024ANICENG28: Type 2 diabetes in adults: management2024ANICEType 2 diabetes in adults: management2024ARACGPEmergency management of hyperglycaemia in primary care2024RACGPIntroduction2024SIGNSIGN 170: Optimising glycaemic control in people with type 1 diabetes2024SIGNSIGN 171: Management of diabetes in pregnancy2024AASLDAASLD Practice Guidance: Clinical Assessment and Management of NAFLD/MASLD2023AWMFS3-Leitlinie Typ-1-Diabetes (AWMF 057-013, 2023)2023CCSCCS 2023 Cardiorenal Risk Reduction Guidelines: GLP-1 RA and SGLT2i2023AWMFDVO-Leitlinie Prophylaxe, Diagnostik und Therapie der Osteoporose v2.2 (2023)2023EASDEvidence-based European recommendations for the dietary management of diabetes (EASD/DNSG 2023)2023GuidelineIDSAIWGDF/IDSA: Diabetic Foot Infections2023WHOWHO Guidelines on Diabetes Management2023AAANPractice Guideline: Treatment of Painful Diabetic Neuropathy2022EASDAutomated insulin delivery: benefits, challenges, and recommendations (ADA/EASD 2022)2022GuidelineEASDManagement of hyperglycaemia in type 2 diabetes, 2022: ADA/EASD Consensus Report2022GuidelineKDIGOKDIGO 2022 Clinical Practice Guideline for Diabetes Management in CKD2022NICEType 1 diabetes in adults: diagnosis and management2022AUSPSTFScreening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.2022EASDDefinition and Interpretation of Remission in Type 2 Diabetes: ADA/EASD Consensus (2021)2021GuidelineEASDThe management of type 1 diabetes in adults: ADA/EASD Consensus Report (2021)2021GuidelineSIGNSIGN 142: Management of Osteoporosis and the Prevention of Fragility Fractures2021USPSTFScreening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement.2021USPSTFScreening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement.2021USPSTFUSPSTF Recommendation: Screening for Prediabetes and Type 2 Diabetes2021EASDGlucose Management for Exercise using CGM Systems in Type 1 Diabetes: EASD Position Statement (2020)2020GuidelineEASDPrecision medicine in diabetes: ADA/EASD Consensus Report (2020)2020GuidelineKDIGOKDIGO 2020: Diabetes in CKD2020AWHOWHO Package of Essential Noncommunicable Disease Interventions (WHO PEN)2020EASDDiabetes digital app technology: benefits, challenges, and recommendations (ADA/EASD 2019)2019GuidelineDiabetes CanadaDiabetes Canada Chapter 1: Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome2018Diabetes CanadaDiabetes Canada Chapter 10: Physical Activity and Diabetes2018Diabetes CanadaDiabetes Canada Chapter 11: Nutrition Therapy2018Diabetes CanadaDiabetes Canada Chapter 12: Glycemic Management in Adults with Type 1 Diabetes2018Diabetes CanadaDiabetes Canada Chapter 13: Pharmacologic Glycemic Management of Type 2 Diabetes in Adults2018Diabetes CanadaDiabetes Canada Chapter 14: Hypoglycemia2018Diabetes CanadaDiabetes Canada Chapter 15: Hyperglycemic Emergencies in Adults2018Diabetes CanadaDiabetes Canada Chapter 16: In-Hospital Management of Diabetes2018Diabetes CanadaDiabetes Canada Chapter 17: Weight Management in Diabetes2018Diabetes CanadaDiabetes Canada Chapter 18: Diabetes and Mental Health2018Diabetes CanadaDiabetes Canada Chapter 19: Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations2018Diabetes CanadaDiabetes Canada Chapter 2: Methods2018Diabetes CanadaDiabetes Canada Chapter 20: Diabetes and Transplantation2018Diabetes CanadaDiabetes Canada Chapter 21: Diabetes and Driving2018Diabetes CanadaDiabetes Canada Chapter 22: Complementary and Alternative Medicine for Diabetes2018Diabetes CanadaDiabetes Canada Chapter 23: Cardiovascular Protection in People with Diabetes2018Diabetes CanadaDiabetes Canada Chapter 24: Screening for the Presence of Cardiovascular Disease2018Diabetes CanadaDiabetes Canada Chapter 25: Dyslipidemia2018Diabetes CanadaDiabetes Canada Chapter 26: Treatment of Hypertension2018Diabetes CanadaDiabetes Canada Chapter 27: Management of Acute Coronary Syndromes2018Diabetes CanadaDiabetes Canada Chapter 28: Treatment of Diabetes in People with Heart Failure2018Diabetes CanadaDiabetes Canada Chapter 29: Chronic Kidney Disease in Diabetes2018Diabetes CanadaDiabetes Canada Chapter 3: Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome2018Diabetes CanadaDiabetes Canada Chapter 30: Retinopathy2018Diabetes CanadaDiabetes Canada Chapter 31: Neuropathy2018Diabetes CanadaDiabetes Canada Chapter 32: Foot Care2018Diabetes CanadaDiabetes Canada Chapter 33: Sexual Dysfunction and Hypogonadism in Men with Diabetes2018Diabetes CanadaDiabetes Canada Chapter 34: Type 1 Diabetes in Children and Adolescents2018Diabetes CanadaDiabetes Canada Chapter 35: Type 2 Diabetes in Children and Adolescents2018Diabetes CanadaDiabetes Canada Chapter 36: Diabetes and Pregnancy2018Diabetes CanadaDiabetes Canada Chapter 37: Diabetes in Older People2018Diabetes CanadaDiabetes Canada Chapter 38: Type 2 Diabetes and Indigenous Peoples2018Diabetes CanadaDiabetes Canada Chapter 4: Screening for Diabetes in Adults2018Diabetes CanadaDiabetes Canada Chapter 41: Cannabis and Diabetes2018Diabetes CanadaDiabetes Canada Chapter 5: Reducing the Risk of Developing Diabetes2018Diabetes CanadaDiabetes Canada Chapter 6: Organization of Diabetes Care2018Diabetes CanadaDiabetes Canada Chapter 7: Self-Management Education and Support2018Diabetes CanadaDiabetes Canada Chapter 8: Targets for Glycemic Control2018Diabetes CanadaDiabetes Canada Chapter 9: Monitoring Glycemic Control2018NICENICE Guideline on Osteoporosis2017ASIGNSIGN 116: Management of Diabetes2017AUSPSTFScreening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement.2017NICENICE Guideline on Non-Alcoholic Fatty Liver Disease2016ASIGNSIGN 116: Management of Diabetes - A National Clinical Guideline2010AWMFAdipositas und SchwangerschaftAWMFAWMF 031-056: SchilddrüsenkarzinomAWMFAWMF 057-023: S2e-Leitlinie Diabetes in der SchwangerschaftS3AWMFChirurgie der Adipositas und metabolischer ErkrankungenAWMFDiabetes und ParodontitisAWMFDiabetes und StraßenverkehrAWMFDiagnostik des Wachstumshormonmangels im Kindes- und JugendalterAWMFDiagnostik und Therapie klinisch hormoninaktiver HypophysentumorenAWMFDiagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im AlterAWMFDiagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und JugendalterAWMFGestationsdiabetes mellitus (GDM), Diagnostik, Therapie und NachsorgeAWMFHormonelle EmpfängnisverhütungAWMFHypoparathyreoidismus und PseudohypoparathyreoidismusAWMFLokaltherapie schwerheilender und/oder chronischer Wunden aufgrund von peripherer arterieller Verschlusskrankheit, Diabetes Mellitus oder chronischer venöser InsuffizienzAWMFNicht-hormonelle EmpfängnisverhütungAWMFOperative Therapie benigner SchilddrüsenerkrankungenAWMFOperative Therapie des primären und renalen HyperparathyreoidismusAWMFOperative Therapie von NebennierentumorenAWMFPrävention und Therapie der AdipositasAWMFPrimärer HyperparathyreoidismusAWMFRadioiodtherapie bei benignen SchilddrüsenerkrankungenAWMFSchilddrüsenkarzinomAWMFSchilddrüsenszintigraphie mit Tc-99m Pertechnetat und I-123 NatriumiodidAWMFSekundärprophylaxe ischämischer Schlaganfall und transitorische ischämische Attacke – Teil 2: Lebensstil, arterielle Stenosen, andere Antithrombotika-Indikationen, Hormone, Diabetes mellitus, SchlafapnoeAWMFSpezielle Diagnostik und Therapie von Netzhautkomplikationen bei DiabetesAWMFTherapie und Prävention der Adipositas im Kindes- und JugendalterAWMFVorgehen bei Neugeborenen von Müttern mit Schilddrüsen-ErkrankungenAWMFZahnimplantate bei Diabetes mellitusCDCCDC Clinical Guidance for Diabetes ScreeningCDCCDC Diabetes Prevention: Risk FactorsCDCCDC Pharmacist Toolkit for Diabetes Prevention: Screen, Test, ReferCDCCDC Prediabetes Risk Test ToolCDCCDC Prediabetes Screening and Risk AssessmentCDCCDC PreventT2 Diabetes Prevention CurriculumInternational Diabetes FederationIDF Clinical Practice Recommendations for Managing Type 2 Diabetes 2023International Diabetes FederationIDF Global Clinical Practice Recommendations for Managing Type 2 Diabetes 2025NICENICE NG144: Osteoporosis: assessing the risk of fragility fracture
Und über 3.000 weitere Leitlinien aus AWMF, NVL, RKI, WHO, NICE u.a.
Häufige Fragen
Ja, ClariMed enthält die Nationale VersorgungsLeitlinie Typ-2-Diabetes sowie weitere endokrinologische AWMF-Leitlinien zu Schilddrüse, Nebenniere und Stoffwechselerkrankungen.
Weitere Fachgebiete
Leitlinien-Suche starten
Durchsuchen Sie Endokrinologie-Leitlinien und tausende weitere Quellen — kostenlos und ohne Anmeldung.
Jetzt suchenStand: 9. April 2026